Lantheus Holdings Acquires Cerveau Technologies
February 6, 2023
Lantheus Holdings, Inc. acquired Knoxville-based Cerveau Technologies, Inc., gaining MK-6240, a clinical-stage F-18 PET imaging agent that targets Tau tangles in Alzheimer's disease. The stock purchase includes upfront and potential milestone payments plus royalty obligations and will expand Lantheus' radiopharmaceutical diagnostic imaging pipeline and research collaborations.
- Buyers
- Lantheus Holdings, Inc.
- Targets
- Cerveau Technologies, Inc.
- Industry
- Pharmaceuticals
- Location
- Tennessee, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.